Suppr超能文献

[功能性单心室中房室瓣反流的外科治疗]

[Surgical management of atrioventricular valve regurgitation in functional single ventricle].

作者信息

Zou M H, Cao F, Ma L, Xia Y S, Yang S C, Chen W D, Li W L, Chen X X

机构信息

Department of Cardiac Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2018 Dec 1;56(12):922-927. doi: 10.3760/cma.j.issn.0529-5815.2018.12.009.

Abstract

To evaluate the early- and mid-term outcomes of surgical atrioventricular valve (AVV) intervention in patients with functional single ventricle (FSV). The clinical data of 40 consecutive FSV patients who underwent surgical AVV intervention between January 2008 and December 2017 at Department of Cardiac Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University were reviewed retrospectively. There were 25 male and 15 female patients. The median age at AVV intervention was 4.5 to 204.0 months ((): 42.5 (59.7) months), and the median body weight was 6.0 to 55.4 kg ((): 13.8 (8.1) kg). The systemic AVV morphology included common AVV in 21 patients, mitral valve in 7 patients, tricuspid valve in 3 patients, and both mitral and tricuspid valve in 9 patients. At first surgical intervention, 15 patients had severe, 25 patients had moderate AVV regurgitation. The timings of the initial surgical intervention were at the first palliative, Glenn, between Glenn and Fontan, and Fontan stage in 5, 23, 4, and 8 patients, respectively. The methods of the initial surgical intervention were AVV repair in 31 patients, AVV replacement in 9 patients. Actuarial survivals were estimated by the Kaplan-Meier method. Prognosis factors for atrioventricular valve reoperation were analyzed using the Cox regression hazard model. There were 6 early deaths, with a mortality of 15.0%. Thirty-four survival patients received a follow-up of 1 to 117 months ((): 44 (34) months). Survival of patients after the initial surgical intervention were 85.0% (95% 74.0% to 95.9%), 79.3% (95% 66.6% to 92.0%), and 79.3% (95% 66.6% to 92.0%) at 1 year, 5 years and 10 years, respectively. In all, only 13 patients completed the Fontan procedure. Six patients underwent 8 reoperations, including AVV replacement in 5 patients, redo AVV repair in 3 patients. Freedom from AVV reoperation at 1 and 5 years was 89.8% (95% 78.8% to 100%) and 79.4% (95% 64.7% to 94.1%), respectively. Multivariate Cox regression analysis revealed that common AVV (=3.53, 95% : 1.63-7.67, =0.020) was the prognosis factors for AVV reoperation. The early- and mid-term outcomes of surgical AVV intervention in FSV patients are not satisfactory. The mortality and reoperation rate are still high, and common AVV predicts the AVV reoperation after the initial surgical intervention.

摘要

评估功能性单心室(FSV)患者手术干预房室瓣(AVV)的早期和中期结果。回顾性分析2008年1月至2017年12月在广州医科大学附属广州市妇女儿童医疗中心心脏外科接受手术AVV干预的40例连续FSV患者的临床资料。其中男性25例,女性15例。AVV干预时的中位年龄为4.5至204.0个月((范围):42.5(59.7)个月),中位体重为6.0至55.4 kg((范围):13.8(8.1)kg)。体循环AVV形态包括21例共同房室瓣、7例二尖瓣、3例三尖瓣以及9例二尖瓣和三尖瓣均有病变。首次手术干预时,15例患者有严重AVV反流,25例患者有中度AVV反流。初始手术干预的时机分别为在首次姑息手术、格林手术、格林手术与Fontan手术之间以及Fontan手术阶段,各阶段分别有5例、23例、4例和8例患者。初始手术干预的方法为31例患者行AVV修复,9例患者行AVV置换。采用Kaplan-Meier法估计精算生存率。使用Cox回归风险模型分析房室瓣再次手术的预后因素。早期死亡6例,死亡率为15.0%。34例存活患者接受了1至117个月的随访((范围):44(34)个月)。初始手术干预后患者1年、5年和10年的生存率分别为85.0%(95%置信区间:74.0%至95.9%)、79.3%(95%置信区间:66.6%至92.0%)和79.3%(95%置信区间:66.6%至92.0%)。总共只有13例患者完成了Fontan手术。6例患者接受了8次再次手术,其中5例患者行AVV置换,3例患者行再次AVV修复。1年和5年免于AVV再次手术的比例分别为89.8%(95%置信区间:78.8%至100%)和79.4%(95%置信区间:64.7%至94.1%)。多因素Cox回归分析显示,共同房室瓣(=3.53,95%置信区间:1.63 - 7.67,=0.020)是AVV再次手术的预后因素。FSV患者手术AVV干预的早期和中期结果并不理想。死亡率和再次手术率仍然很高,并且共同房室瓣预示着初始手术干预后AVV再次手术的发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验